Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950123-20-006683

President sold 50,000 shares at $80.00 ($4,000,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Novak Rodger President 2020-07-01 Sale −50,000 $80.00 $4,000,000 648,007 D
Open-market sales · 50,000 sh · avg $80.00 · $4,000,000
Loading xslF345X03/doc4.xml…